Skip to main content
. 2020 Apr 20;21(8):2866. doi: 10.3390/ijms21082866

Figure 5.

Figure 5

(a) Representative dot blot of HUVEC cells untreated (left) or exposed to VEGF73-101 (right) for 72 h; (b) the amount of viable, apoptotic and late apoptotic/dead HUVEC cells treated with VEGF73-101, VEGF84-101, VEGFQ79G, and VEGFI83G (5 µM), compared to untreated cells and those treated with STS (staurosporine) added 2 h before analysis. Data are the mean ± SEM of two different experiments performed in triplicate. Statistically significant differences are indicated with * = p < 0.05 vs. CTRL (One-Way ANOVA + Tukey’s test Student-Newman-Keuls test).